Greystone Refinances SoCal Multifamily Portfolio for $41.6

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
51
Greystone Refinances SoCal Multifamily Portfolio for $41.6 Million

NEW YORK, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Greystone, a real estate lending, investment and advisory company, today announced it has provided $41,648,000 in Fannie Mae financing on a Malik Corporation property portfolio in Southern California. The loans were originated by Matt Stevens of Greystone’s San Diego office with Don Salka of First Pacific Financial acting as correspondent on the transaction.

The refinanced properties, which all contain between 8 and 32 units, all received 10-year fixed rate Fannie Mae small loans. The Class “A” properties are located in Brentwood, Studio City, Beverly Hills adjacent, Century City, and Hancock Park.

“Fannie Mae’s small loan platform is increasingly competitive, offering a number of advantages for property owners to refinance an entire portfolio of holdings at one time,” said Mr. Stevens. “We appreciate the opportunity to help the Malik Corporation optimize their portfolio and take advantage of the fantastic terms offered by Fannie Mae.”

“Greystone has proven to be a reliable and trusted partner, and we appreciate their guidance and ability to execute on all levels,” said Mr. Salka.

About Greystone Greystone is a real estate lending, investment and advisory company with an established reputation as a leader in multifamily and healthcare finance, having ranked as a top FHA and Affordable Fannie Mae lender in these sectors. Our range of services includes commercial lending across a variety of platforms such as Fannie Mae, Freddie Mac, CMBS, FHA, USDA, bridge and proprietary loan products. Loans are offered through Greystone Servicing Corporation, Inc., Greystone Funding Corporation and/or other Greystone affiliates. For more information, visit www.greyco.com .

PRESS CONTACT: Karen Marotta Greystone 212-896-9149 Karen.Marotta@Greyco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading